|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,756 GBX | -1.07% |
|
-2.98% | +21.09% |
| 04:26pm | GSK Says Depemokimab Reduced Asthma Attacks in 2 Late-Stage Studies | MT |
| 02:03pm | GSK's Potential Blockbuster Asthma Drug Shows Promise in Latest Trial -- 2nd Update | DJ |
GSK plc reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was GBP 7,363 million compared to GBP 6,951 million a year ago. Net income was GBP 1,046 million compared to GBP 1,490 million a year ago.
Basic earnings per share from continuing operations was GBP 0.257 compared to GBP 0.368 a year ago. Diluted earnings per share from continuing operations was GBP 0.254 compared to GBP 0.365 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +21.09% | 91.96B | |
| +37.87% | 705B | |
| +32.82% | 583B | |
| -3.73% | 364B | |
| +19.82% | 332B | |
| +5.17% | 291B | |
| +16.64% | 238B | |
| -4.13% | 210B | |
| +10.63% | 209B | |
| +9.23% | 169B |
GSK PLC 
